News
Eli Lilly Shares Up 13% After Weight Loss Pill Appears As Effective As Ozempic And Mounjaro In Trials
Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily weight loss pill, orforglipron, demonstrated effectiveness consistent with other injectable GLP-1 weight loss drugs, such as Lilly’s Mounjaro and Novo Nordisk’s Ozempic.
Let's look at why this news could be a game-changer for Eli Lilly and its stock.
Newspoint on MSN3h
Weight loss drug Mounjaro launched in India, now it will be available officially, cost is just this muchAmerica's famous drug manufacturer Eli Lilly has launched the weight loss drug Mounjaro in India. This drug is already quite ...
U.S. pharma giant Eli Lilly And Co (NYSE:LLY) announced the launch of its popular weight loss drug Mounjaro (tirzepatide) in ...
Over the last couple of years, one of the best pharma stocks to own has been Eli Lilly ( LLY 14.56%). But now, an investment ...
We recently published a list of 10 Best Low Volatility Stocks to Buy Now. In this article, we are going to take a look at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback